AGP Executive Report
Last update: 2 hours agoWomen’s Health: A post hoc analysis of phase 3 trials found elinzanetant improved reported sleep symptoms in women with moderate-to-severe menopause-related hot flashes. Separate long-term research linked premature menopause to higher cardiovascular risk, with insulin resistance explaining part—but not all—of the association. New Treatments: The FDA approved bepirovirsen, the first antisense treatment for chronic hepatitis B, for some adults without cirrhosis; trial results suggest some patients may stop ongoing antiviral therapy. Ten-year multiple sclerosis data also favor starting ocrelizumab early, with fewer relapses and less disability progression. Healthcare Systems: The UAE plans to bring existing health services under one national system. Abu Dhabi also introduced a framework for studying when AI systems could perform clinical tasks, with physician oversight and safeguards. Coverage and Costs: Rising premiums and potential policy changes could leave more Americans uninsured or underinsured, raising concerns about delayed care and medical debt.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
